$CWBR
CohBar Inc

2023 Q3 Form 10-Q Financial Statement

#000121390023067030 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.254M $435.0K
YoY Change 878.14% -54.58%
% of Gross Profit
Research & Development $178.9K $1.187M
YoY Change -84.93% -54.66%
% of Gross Profit
Depreciation & Amortization $920.00 $32.24K
YoY Change -97.15% -1.89%
% of Gross Profit
Operating Expenses $4.433M $2.744M
YoY Change 61.58% -47.26%
Operating Profit -$4.433M -$2.744M
YoY Change 61.58% -47.26%
Interest Expense $101.0K $18.72K
YoY Change 439.53% -187.8%
% of Operating Profit
Other Income/Expense, Net $101.0K $18.72K
YoY Change 439.6% -187.77%
Pretax Income -$4.332M -$2.725M
YoY Change 58.99% -47.83%
Income Tax
% Of Pretax Income
Net Earnings -$4.332M -$2.725M
YoY Change 58.99% -47.83%
Net Earnings / Revenue
Basic Earnings Per Share -$1.49 -$0.03
Diluted Earnings Per Share -$1.49 -$31.33K
COMMON SHARES
Basic Shares Outstanding 2.907M shares 2.907M shares 86.98M shares
Diluted Shares Outstanding 2.907M shares 2.899M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.31M $20.10M
YoY Change -38.74% 45.38%
Cash & Equivalents $6.192M $2.878M
Short-Term Investments $6.119M $17.22M
Other Short-Term Assets $119.7K $1.068M
YoY Change -88.79% 2.13%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.47M $21.17M
YoY Change -41.07% 42.33%
LONG-TERM ASSETS
Property, Plant & Equipment $1.728K $196.2K
YoY Change -99.12% -40.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.48K $76.60K
YoY Change -82.41% 10.02%
Total Long-Term Assets $32.67K $291.5K
YoY Change -88.79% -29.8%
TOTAL ASSETS
Total Short-Term Assets $12.47M $21.17M
Total Long-Term Assets $32.67K $291.5K
Total Assets $12.51M $21.46M
YoY Change -41.72% 40.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.376M $308.6K
YoY Change 345.79% -83.39%
Accrued Expenses $498.4K $76.67K
YoY Change 550.06% -91.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $3.002M $743.8K
YoY Change 303.57% -76.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.002M $743.8K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.002M $743.8K
YoY Change 303.57% -76.26%
SHAREHOLDERS EQUITY
Retained Earnings -$103.4M -$90.72M
YoY Change 13.98%
Common Stock $2.907K $86.98K
YoY Change -96.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.504M $20.71M
YoY Change
Total Liabilities & Shareholders Equity $12.51M $21.46M
YoY Change -41.72% 40.37%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$4.332M -$2.725M
YoY Change 58.99% -47.83%
Depreciation, Depletion And Amortization $920.00 $32.24K
YoY Change -97.15% -1.89%
Cash From Operating Activities -$1.803M -$3.412M
YoY Change -47.15% -21.15%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $2.603M $4.726M
YoY Change -44.92% 25.07%
Cash From Investing Activities $2.603M $4.726M
YoY Change -44.92% 25.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.803M -3.412M
Cash From Investing Activities 2.603M 4.726M
Cash From Financing Activities 0.000 0.000
Net Change In Cash 800.0K 1.314M
YoY Change -39.13% -721.62%
FREE CASH FLOW
Cash From Operating Activities -$1.803M -$3.412M
Capital Expenditures $0.00
Free Cash Flow -$3.412M
YoY Change -21.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenues
Revenues
usd
us-gaap Interest Expense Other
InterestExpenseOther
usd
CY2023Q2 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q2 us-gaap Revenues
Revenues
usd
CY2022Q2 us-gaap Revenues
Revenues
usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2899390 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.07
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2895158 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38326
dei Entity Registrant Name
EntityRegistrantName
COHBAR, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1299952
dei Entity Address Address Line1
EntityAddressAddressLine1
1455 Adams Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1308
dei Entity Address City Or Town
EntityAddressCityOrTown
Menlo Park
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
dei City Area Code
CityAreaCode
(650)
dei Local Phone Number
LocalPhoneNumber
446-7888
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
CWBR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2906926 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6192343 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5930731 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
6119012 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
9806591 usd
CY2023Q2 cwbr Vendor Receivable
VendorReceivable
42323 usd
CY2022Q4 cwbr Vendor Receivable
VendorReceivable
27500 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
119742 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
453681 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 us-gaap Assets Current
AssetsCurrent
12473420 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
16218503 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1728 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65509 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
17469 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
18083 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13476 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
63572 usd
CY2023Q2 us-gaap Assets
Assets
12506093 usd
CY2022Q4 us-gaap Assets
Assets
16365667 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1375742 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
180104 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
498377 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
327868 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1127786 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
525666 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3001905 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1033638 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2906926 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2906926 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2906926 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2906926 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
2907 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2907 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
112908754 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
112238392 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-103407473 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96909270 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9504188 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15332029 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12506093 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16365667 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
178862 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1186900 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1199601 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2693208 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4254487 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1556785 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5533760 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3301703 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
4433349 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2743685 usd
us-gaap Operating Expenses
OperatingExpenses
6733361 usd
us-gaap Operating Expenses
OperatingExpenses
5994911 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4433349 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2743685 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6733361 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5994911 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
100997 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
18717 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
235158 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
18717 usd
us-gaap Interest Expense Other
InterestExpenseOther
1824 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-8723 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
100997 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18717 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
235158 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8170 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4332352 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2724968 usd
us-gaap Net Income Loss
NetIncomeLoss
-6498203 usd
us-gaap Net Income Loss
NetIncomeLoss
-5986741 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.49
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.07
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2906926 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2899390 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2906926 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2895158 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15332029 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
337601 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2165851 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
13503779 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
332761 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4332352 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9504188 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25607827 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
456423 usd
CY2022Q1 cwbr Stock Issue Duringperiod Value Sale Of Common Stock In Atm Net
StockIssueDuringperiodValueSaleOfCommonStockInATMNet
200624 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3261773 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
23003101 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
434956 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2724968 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
20713089 usd
us-gaap Net Income Loss
NetIncomeLoss
-6498203 usd
us-gaap Net Income Loss
NetIncomeLoss
-5986741 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
64395 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
65044 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
22975 usd
us-gaap Share Based Compensation
ShareBasedCompensation
670362 usd
us-gaap Share Based Compensation
ShareBasedCompensation
891379 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8350 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
373 usd
cwbr Discount On Investments
DiscountOnInvestments
17579 usd
cwbr Discount On Investments
DiscountOnInvestments
36687 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
14823 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-173499 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-333939 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
540753 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1195638 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-63388 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
170509 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-119354 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
602120 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-395742 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
50096 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-6976 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3431363 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5937622 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
22975 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
13283000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
34140000 usd
cwbr Proceeds From Redemptions Of Investments
ProceedsFromRedemptionsOfInvestments
16953000 usd
cwbr Proceeds From Redemptions Of Investments
ProceedsFromRedemptionsOfInvestments
38138000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3692975 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3998000 usd
cwbr Proceeds From The Atthe Market Offering Net
ProceedsFromTheAttheMarketOfferingNet
200624 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-375000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-174376 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
261612 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2113998 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5930731 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4992145 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6192343 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2878147 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
800 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1333 usd
us-gaap Interest Paid Net
InterestPaidNet
114411 usd
cwbr Capital Stock Outstanding Shares Percentage
CapitalStockOutstandingSharesPercentage
0.77 pure
CY2023Q2 us-gaap Cash
Cash
4000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
4000000 usd
us-gaap Payments For Fees
PaymentsForFees
3000000 usd
us-gaap Investment Company Excess Expense Reimbursable
InvestmentCompanyExcessExpenseReimbursable
1500000 usd
CY2023Q2 us-gaap Investments And Cash
InvestmentsAndCash
12300000 usd
CY2023Q2 cwbr Working Capital
WorkingCapital
9500000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
9500000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-variant: small-caps"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at dates of the financial statements and the reported amounts of revenue and expenses during the periods. Actual results could differ from these estimates. The Company’s significant estimates and assumptions include the fair value of financial instruments, stock-based compensation and the valuation allowance relating to the Company’s deferred tax assets.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-variant: small-caps"><b><i>Concentrations of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company maintains deposits in a financial institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk.</p>
cwbr Royalties Ranging Percentage
RoyaltiesRangingPercentage
0.08 pure
CY2023Q2 us-gaap Retail Land Sales Receivables Stated Interest Rate
RetailLandSalesReceivablesStatedInterestRate
0.12 pure
us-gaap Operating Lease Cost
OperatingLeaseCost
13080 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
27000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000 usd
CY2023Q2 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
6100000 usd
CY2022Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
9800000 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2200000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3900000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
100000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
200000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2000000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1428236 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1508379 shares
CY2022Q4 cwbr Lab Services Supplies
LabServicesSupplies
160482 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
442719 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
167386 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
55658 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
498377 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
327868 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
400000 usd
cwbr Debt Interest Amount
DebtInterestAmount
100000 usd
cwbr Issuance And Sale Of Stock
IssuanceAndSaleOfStock
17000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
cwbr Amount Of Atm Availability
AmountOfATMAvailability
200000 usd
us-gaap Multiemployer Plans Collective Bargaining Arrangement Expiration Date Description
MultiemployerPlansCollectiveBargainingArrangementExpirationDateDescription
The Company’s ATM program expires in September 2023.
cwbr Options To Purchase Common Stock
OptionsToPurchaseCommonStock
66900 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
317857 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
194853 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.53
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
38.53
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
38.53
CY2022Q4 cwbr Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 One
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2One
P6Y11M26D
cwbr Stock Options Outstanding Share Based Compensation Arrangement By Share Based Payment Award Option Forfeitures And Expirations In Periodding Cancelledin Share
StockOptionsOutstandingShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeituresAndExpirationsInPerioddingCancelledinShare
66936 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
250921 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
159706 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.05
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
35.92
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
35.92
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M7D
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
250921 shares
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
159742 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q2 us-gaap Percentage Of Interest Bearing Domestic Deposits To Deposits Money Market
PercentageOfInterestBearingDomesticDepositsToDepositsMoneyMarket
0.85 pure
us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
10500 shares
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
332761 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
434956 usd
us-gaap Share Based Compensation
ShareBasedCompensation
670362 usd
us-gaap Share Based Compensation
ShareBasedCompensation
891379 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
607 usd
CY2022Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
32244 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
64395 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
65044 usd
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
333368 usd
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
467200 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
734757 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
956423 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8350 usd
us-gaap Other Expenses
OtherExpenses
8350 usd
CY2023Q2 cwbr Total Noncash Expenses
TotalNoncashExpenses
333368 usd
CY2022Q2 cwbr Total Noncash Expenses
TotalNoncashExpenses
467200 usd
cwbr Total Noncash Expenses
TotalNoncashExpenses
734757 usd
cwbr Total Noncash Expenses
TotalNoncashExpenses
964773 usd
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Revenues
Revenues
usd
CY2023Q2 us-gaap Interest Expense Other
InterestExpenseOther
usd
CY2022Q2 us-gaap Interest Expense Other
InterestExpenseOther
usd
CY2022Q2 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.24
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2906926 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2906926 shares
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
cwbr Proceeds From The Atthe Market Offering Net
ProceedsFromTheAttheMarketOfferingNet
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 cwbr Lab Services Supplies
LabServicesSupplies
usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
cwbr Share Based Compensation Arrangement By Share Based Payment Award Option Grants
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrants
shares
cwbr Share Based Compensation Arrangement By Shares Based Payment Award Options Exercisable Granted.
ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsExercisableGranted.
shares
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceGranted
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodWeightedAverageGrantDateFairValue
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Contractual Life Years
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualLifeYears
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercised
shares
cwbr Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercised
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercised
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Exercise
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceExercise
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercised Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisedDateFairValue
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Contractual Life Years
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedContractualLifeYears
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue
usd
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableCancelled
shares
cwbr Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Cancelled
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelled
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceCancelled
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Cancelled Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelledDateFairValue
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Cancelledd Contractual Life Years
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelleddContractualLifeYears
cwbr Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue
usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
usd
us-gaap Other Expenses
OtherExpenses
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001522602

Files In Submission

Name View Source Status
cwbr-20230630_lab.xml Edgar Link unprocessable
cwbr-20230630_cal.xml Edgar Link unprocessable
cwbr-20230630_pre.xml Edgar Link unprocessable
0001213900-23-067030-index-headers.html Edgar Link pending
0001213900-23-067030-index.html Edgar Link pending
0001213900-23-067030.txt Edgar Link pending
0001213900-23-067030-xbrl.zip Edgar Link pending
cwbr-20230630.xsd Edgar Link pending
f10q0623ex31-1_cohbarinc.htm Edgar Link pending
f10q0623ex31-2_cohbarinc.htm Edgar Link pending
f10q0623ex32-1_cohbarinc.htm Edgar Link pending
f10q0623_cohbarinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
cwbr-20230630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0623_cohbarinc_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending